恒定自然杀伤T细胞亚群在预防移植物抗宿主病和抗肿瘤方面具有不同作用
该研究在小鼠中生成高纯度iNKT1、iNKT2和iNKT17亚群,并分析其转录组、表观基因组及功能。结果显示iNKT2和iNKT17可抑制T细胞活化并减轻急性GVHD,而iNKT1对B细胞淋巴瘤的抗肿瘤活性最强。首次揭示iNKT亚群功能分化,对iNKT细胞疗法的临床转化有重要意义。
要点
- iNKT2和iNKT17亚群抑制T细胞活化并减轻小鼠急性GVHD。
- iNKT1亚群体内外均显示最高的抗B细胞淋巴瘤活性。
- iNKT亚群功能不同,需针对性选择亚群用于临床转化。
核心结论
- iNKT亚群功能分化:iNKT1抗肿瘤最强,iNKT2和iNKT17具有免疫调节和抑制GVHD作用。
研究设计与样本
- 研究生成高纯度小鼠iNKT1、iNKT2和iNKT17亚群,并表征其转录组和表观基因组 landscape。
主要发现
- iNKT2和iNKT17(而非iNKT1)在体外有效抑制T细胞活化,并在体内减轻小鼠急性GVHD。
- iNKT1在体外和体内对小鼠B细胞淋巴瘤细胞均显示最高的抗肿瘤活性。
临床怎么用
- 提示iNKT细胞疗法临床转化时,应根据治疗目标(抗肿瘤或预防/治疗GVHD)选择特定亚群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invariant natural killer T (iNKT) cells are a T-cell subset with potent immunomodulatory properties. Experimental evidence in mice and observational studies in humans indicate that iNKT cells have antitumor potential as well as the ability to suppress acute and chronic graft-versus-host-disease (GVHD). Murine iNKT cells differentiate during thymic development into iNKT1, iNKT2, and iNKT17 sublineages, which differ transcriptomically and epigenomically and have subset-specific developmental requirements. Whether distinct iNKT sublineages also differ in their antitumor effect and their ability to suppress GVHD is currently unknown. In this work, we generated highly purified murine iNKT sublineages, characterized their transcriptomic and epigenomic landscape, and assessed specific functions. We show that iNKT2 and iNKT17, but not iNKT1, cells efficiently suppress T-cell activation in vitro and mitigate murine acute GVHD in vivo. Conversely, we show that iNKT1 cells display the highest antitumor activity against murine B-cell lymphoma cells both in vitro and in vivo. Thus, we report for the first time that iNKT sublineages have distinct and different functions, with iNKT1 cells having the highest antitumor activity and iNKT2 and iNKT17 cells having immune-regulatory properties. These results have important implications for the translation of iNKT cell therapies to the clinic for cancer immunotherapy as well as for the prevention and treatment of GVHD.
引用
- Maas-Bauer K, Lohmeyer JK, Hirai T, et al. Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood. 2021. PMID: 34036317. doi:10.1182/blood.2021010887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。